歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 其他抗體 > TSG101 抗原(重組蛋白)

產(chǎn)品中心

  • TSG101 抗原(重組蛋白)

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW17828
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:90
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱TSG101 抗原(重組蛋白)

英文名稱 TSG101 Antigen (Recombinant Protein)

      名: tumor susceptibility 101; TSG10; VPS23

儲(chǔ)      存: 冷凍(-20℃)

相關(guān)類別 抗原

概  述:

Fusion protein corresponding to a region derived from 2-145 amino acids of human TSG101

  
技術(shù)規(guī)格:

Full name:

tumor susceptibility 101

Synonyms:

TSG10; VPS23

Swissprot:

Q99816

Gene Accession:

BC002487

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression.